CAS 1093070-16-6

GRL0617

CAS: 1093070-16-6

GRL0617 is a selective and competitive SARS-CoVPLpro and deubiquitinase noncovalent inhibitor(IC50 : 0.6 μM, Ki : 0.49 μM).

Fórmula: C₂₀H₂₀N₂O

Pureza: 99.31%

Cor e Forma: Solid

Peso molecular: 304.39

Ref: TM-T11464

GRL0617

CAS: 1093070-16-6

Fórmula: C₂₀H₂₀N₂O

Pureza: 99%

Cor e Forma: Solid

Peso molecular: 304.3856

Ref: IN-DA01KKBV

GRL0617

CAS: 1093070-16-6

GRL0617

Pureza: ≥98%

Peso molecular: 304.39g/mol

Ref: 54-BUP12825

GRL 0617

CAS: 1093070-16-6

A novel non-covalent inhibitor of the PLpro protease from SARS-CoV-2 and SARS-CoV viruses. GRL 0617 inhibits the proteolytic processing of the viral polypeptide. As PLpro also acts as a protease in pathways involved in innate immunity, there are indications that it can promote immunity against the virus.

Fórmula: C₂₀H₂₀N₂O

Pureza: Min. 98 Area-%

Cor e Forma: Powder

Peso molecular: 304.39 g/mol

Ref: 3D-BG178727